期刊文献+

经皮椎体成形术联合唑来膦酸治疗骨质疏松性椎体压缩骨折的疗效观察 被引量:7

原文传递
导出
摘要 目的探讨经皮椎体成形术联合唑来膦酸治疗骨质疏松性椎体压缩骨折的临床疗效。方法回顾性分析自2015-04—2020-03诊治的61例骨质疏松性椎体压缩骨折,29例采用经皮椎体成形术联合唑来膦酸治疗(观察组),32例单纯采用经皮椎体成形术治疗(对照组)。比较2组骨折愈合时间以及术后1年疼痛VAS评分、ODI指数、椎体前缘高度、伤椎Cobb角、腰椎骨密度值、髋部骨密度值。结果 2组均顺利完成手术并获得至少1年的随访。2组术后均未出现神经根压迫、感染、骨水泥渗漏、肺栓塞及脊髓功能障碍等并发症。2组骨折愈合时间比较差异无统计学意义(P>0.05)。术后1年2组疼痛VAS评分、ODI指数、椎体前缘高度、伤椎Cobb角比较差异无统计学意义(P>0.05);观察组腰椎骨密度值与髋部骨密度值较对照组高,差异有统计学意义(P<0.05)。结论经皮椎体成形术联合唑来膦酸治疗骨质疏松性椎体压缩骨折可以取得满意的临床疗效,患者术后骨密度值恢复满意。
出处 《中国骨与关节损伤杂志》 2021年第9期949-950,共2页 Chinese Journal of Bone and Joint Injury
  • 相关文献

参考文献10

二级参考文献108

  • 1张欢,张帆,吴林珍,崔文慧.西安市中老年居民运动机能综合评价标准的应用研究[J].西安体育学院学报,2006,23(5):82-86. 被引量:2
  • 2Center JR, Nguyen TV, Schneider D, et al. Mortality after all major types of osteoporotic fracture in men and women: an observational study [J]. Lancet, 1999, 353 (9156) : 878-882.
  • 3Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures [J]. Lancet, 2002, 359 (9319) : 1761-1767.
  • 4Harris ST, Watts NB, Genant HK, et aL Effects ofrisedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial[J]. JAm Med Asscoi, 1999, 282 (14) : 1344-1352.
  • 5McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women[J]. N Engl J Med, 2001, 344 (5) : 333-340.
  • 6Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis [J]. Osteoporos Int, 2000, Ⅱ (1): 83-91.
  • 7Siris ES, Harris ST, Rosen C J, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women relationship to vertebral and nonverterbal fractures from 2 US claims databases [J]. Mayo Clinc Proc, 2006, 81 (8) : 1013-1022.
  • 8Caro JJ, Ishak KJ, Huybrechts KF, et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice[J]. Osteoporos Int, 2004, 15 (12) : 1003-1008.
  • 9McCombs JS, Thiebaud P, McLaughlin-Miley C, et al. Compliance with drug therapies for the treatment and prevention of osteoporosis[J]. Maturitas, 2004, 48 (3):271-287.
  • 10Chapurlat D. Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture [J]. Ther Clin Risk Manag, 2009, 5 (2): 169-175.

共引文献187

同被引文献61

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部